Mary Tyler Moore Vision Initiative Marks 5th Annual Symposium on Curing Vision Loss from Diabetes
Hosted in collaboration with the University of Michigan’s Elizabeth Weiser Caswell Diabetes Institute and Kellogg Eye Center, the symposium convened researchers, clinicians, people affected by diabetes, and leaders from industry, government and regulatory agencies around a shared goal: accelerating progress toward preventing, treating and ultimately curing vision loss caused by diabetic retinal disease.
The annual gathering provides an important forum for sharing emerging science, strengthening cross-sector partnerships and identifying opportunities to move discoveries toward better diagnostics and treatments. The work extends well beyond the symposium through Mary Tyler Moore Vision Initiative programs focused on biomarkers and clinical endpoints, human ocular tissue and data resources, collaborative research and public-private partnerships.
That collaborative model is increasingly important. No single researcher, institution or sector can solve the complex challenges of diabetic retinal disease alone. Progress requires bringing together scientific discovery, clinical expertise, industry innovation and the experiences of people living with diabetes.
For Alliance for Vision Research, the symposium also reflects why sustained investment in vision research matters. Breakthroughs depend on a strong research ecosystem that gives scientists the resources, infrastructure and partnerships necessary to pursue discoveries and translate them into better outcomes for patients.

The Mary Tyler Moore Vision Initiative was founded by S. Robert Levine, MD, to carry forward Mary Tyler Moore’s commitment to diabetes research and her hope for a future in which people with diabetes no longer have to fear losing their sight.
Five years into this annual symposium, that vision continues to bring a remarkable community together around a powerful goal: a world without vision loss from diabetes.